Typewriter Therapeutics raised $56M in Series A funding.
- Amount
- $56M
- Stage
- Series A
- Announced
- 2 September 2026
- Leads
- AN Venture Partners, RA Capital Management
- Other investors
- ANRI, Gemseki, SBI US Gateway Fund
- Use of funds
- Typewriter will use the funds to progress its non-viral gene therapy platform closer to the clinic.
- Checked
- Amount and date checked against the press source